Enroute Sales Solutions was setup to meet the needs of companies in the US and United Kingdom who are looking to address the French or European market and require someone in the right geography with relevant experience, langauge and contacts.

For a variety of reasons clients may not be in the position to hire a fulltime business development professional in France and Enroute Sales Solutions can help them fill this role on a part-time or contract basis dependent on their exact needs.

Enroute Sales Solutions was setup by Karen Watson-Robin
to meet the needs of companies in the US and United Kingdom who are looking to address the French or European market and require someone in the right geography with relevant experience and contacts.

Karen, has over 20 years of business development experience internationally. She has lived in the countryside west of Paris for over 10 years and is married to a senior officer in the French gendarmerie. A native English speaker Karen also speaks fluent French.

For the last 15 years Karen has been focused on the pharmaceutical industry where she has held senior business development positions working internationally with the US and other European countries.

A clear understanding from clinical development to commercialization services.

Having worked for different companies in different roles, Karen has direct experience of clinical development, data management and statistics, EDC, market research and sales force contracting. She is therefore able to quickly understand your market, products or services and rapidly implement a successful sales strategy.

Though, clearly, Karen's primary experience is within the pharmaceutical industry, She is equally enthusiastic about working within other industries to use her business development experience, French language and cultural expertise. For example, Karen also has direct experience of working in the defence and security market.

Experience

Karen Watson-Robin
Senior Consultant

• Cambridge University
• Price Waterhouse
• Hewlett Packard
  
• Financial Times
  
• Datamonitor
  
• Source Informatics
  
• Innovex
  
• Dendrite Clinical
  
• i3